Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 5/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7714670 | 0.94 | ADRB2 (0.33) | ADRB2ADRB3ADRB1MAPTNPSR1 | |
| SCHEMBL7716950 | 0.92 | ADRB2 (0.32) | ADRB2ADRB3ADRB1 | |
| SCHEMBL7709011 | 0.92 | NR1H2 (0.32) | ADRB2ADRB3ADRB1 | |
| SCHEMBL7712721 | 0.89 | RPS6KB1 (0.30) | — | |
| SCHEMBL7708894 | 0.86 | ADRB2 (0.32) | ADRB2ADRB3ADRB1 | |
| SCHEMBL7714945 | 0.85 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL7714622 | 0.84 | — | — | |
| SCHEMBL7714803 | 0.84 | PDCD1 (0.33) | MAPT | |
| SCHEMBL8586129 | 0.83 | ADRB3 (0.37) | ADRB2ADRB3ADRB1MAPT | |
| SCHEMBL8586133 | 0.83 | ADRB3 (0.37) | ADRB2ADRB3ADRB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0865421-B1 | ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS | GLAXO GROUP LTD (GB) | 2002-03-27 | — | — | EP | disclosed |
| US-6048872-A | DIETETICS; ANTIDIABETIC AGENTS; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS | GLAXO WELLCOME INC. (US) | 2000-04-11 | — | — | US | disclosed |